histidine has been researched along with alpha-synuclein in 24 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (25.00) | 29.6817 |
2010's | 15 (62.50) | 24.3611 |
2020's | 3 (12.50) | 2.80 |
Authors | Studies |
---|---|
Hachiya, NS; Jozuka, A; Kaneko, K; Sakasegawa, Y; Sasaki, H; Tsukita, S | 1 |
Giasson, BI; Hodara, R; Ischiropoulos, H; Lee, VM; Norris, EH; Trojanowski, JQ; Xu, S | 1 |
Andersen, PM; Collinge, J; Fisher, EM; Hardiman, O; Highley, R; Ince, PG; Morrison, KE; Pall, HS; Parkinson, N; Shaw, PJ; Skibinski, G; Smith, MO | 1 |
Boyer, F; Dreyer, JL | 1 |
Grzonka, Z; Jankowska, E; Kowalik-Jankowska, T; Rajewska, A | 1 |
Brown, DR | 1 |
Benfatto, M; Bisaglia, M; Bortolus, M; Bubacco, L; Fittipaldi, M; Maniero, AL; Zoleo, A | 1 |
Baratto, MC; Camponeschi, F; Kozlowski, H; Luczkowski, M; Remelli, M; Valensin, D; Valensin, G | 1 |
Barnes, CO; Monteith, WB; Pielak, GJ | 1 |
Cobb, SA; Englund, E; Farrer, MJ; Kachergus, JM; Lincoln, SJ; Nilsson, C; Puschmann, A; Rehncrona, S; Ross, OA; Törnqvist, AL; Vilariño-Güell, C; Widner, H; Wszolek, ZK | 1 |
Aasly, JO; Appel-Cresswell, S; Encarnacion, M; Farrer, MJ; Jon Stoessl, A; Rajput, A; Rajput, AH; Shah, B; Sherman, H; Szu-Tu, C; Thompson, C; Trinh, J; Vilarino-Guell, C; Weir, D; Yu, I | 1 |
Armstrong, GS; Chi, YC; Eisenmesser, EZ; Jones, DN; Liu, CW | 1 |
Binolfi, A; Fernández, CO; Griesinger, C; Miotto, MC; Zweckstetter, M | 1 |
Cai, Z; Chen, LL; Chua, KK; Li, M; Liu, LF; Luan, H; Meng, N; Mok, VC; Song, JX; Tang, Z; Xie, LX | 1 |
Becker, CM; Hoffmann, AC; Klucken, J; Meixner, H; Menges, S; Schlachetzki, JC; Schlötzer-Schrehardt, U; Winkler, J; Xiang, W | 1 |
Casella, L; De Ricco, R; Dell'Acqua, S; Dorlet, P; Faller, P; Hureau, C; Valensin, D | 1 |
Carlomagno, Y; DeTure, M; Dickson, DW; Hinkle, KM; Lin, WL; Pedraza, O; Rademakers, R; Ross, OA; Sanchez-Contreras, M; Tacik, P; Wszolek, ZK | 1 |
Kumar, A; Ranjan, P | 1 |
Abad Gonzalez, E; Carija, A; Carloni, P; Fernández, CO; Foguel, D; Fonseca-Ornelas, L; Gerhardt, E; Lopes da Fonseca, T; Masaracchia, C; Milosevic, I; Outeiro, TF; Pinho, R; Rossetti, G; Sant'Anna, R; Szegö, ÉM; Ventura, S; Villar-Piqué, A; Zweckstetter, M | 1 |
Choi, S; Hwang, H; Kim, D; Kim, S; Ko, HS; Kwon, SH; Lee, S; Park, JH | 1 |
Funayama, M; Hattori, N; Li, Y; Matsuura, E; Nishioka, K; Takanashi, M; Takashima, H; Tsuyama, S; Yoshino, H | 1 |
Amininasab, M; Davoodi, J; Saffari, B; Sheikhi, S | 1 |
Castañeda-Hernández, G; Fernández, CO; González, FJ; Quintanar, L; Ríos, A; Rodríguez, EE; Trujano-Ortiz, LG; Villegas, A | 1 |
Chiu, YW; Hirayama, K; Hori, Y; Ikeda, T; Iwai, A; Iwata, A; Kanai, M; Mano, T; Nakamura, R; Sohma, Y; Suzuki, T; Tarutani, A; Toda, T; Tomita, T; Tomizawa, I | 1 |
24 other study(ies) available for histidine and alpha-synuclein
Article | Year |
---|---|
Oligomeric Aip2p/Dld2p modifies the protein conformation of both properly folded and misfolded substrates in vitro.
Topics: Actins; Adenosine Triphosphate; alpha-Synuclein; Amyloid beta-Peptides; Cell Cycle; Chromatography, Gel; Deoxyribonuclease I; Histidine; Hydrolysis; L-Lactate Dehydrogenase; L-Lactate Dehydrogenase (Cytochrome); Molecular Chaperones; Nerve Tissue Proteins; Protein Conformation; Protein Denaturation; Protein Folding; Protein Structure, Secondary; Recombinant Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Substrate Specificity; Surface Plasmon Resonance; Synucleins; Trypsin | 2004 |
Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.
Topics: alpha-Synuclein; Amino Acid Motifs; Circular Dichroism; DNA, Complementary; Dopamine; Histidine; Humans; Indolequinones; Methionine; Microscopy, Atomic Force; Microscopy, Electron; Mutagenesis; Mutation; Nerve Tissue Proteins; Oxidative Stress; Oxygen; Parkinson Disease; Peptides; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Synucleins; Time Factors; Tyrosine | 2005 |
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B).
Topics: Adaptor Proteins, Signal Transducing; Aged; alpha-Synuclein; Amyotrophic Lateral Sclerosis; Brain; DNA Mutational Analysis; Endosomal Sorting Complexes Required for Transport; Glial Fibrillary Acidic Protein; Glutamine; Histidine; Humans; Immunohistochemistry; Isoleucine; Male; Mutation; Nerve Tissue Proteins; Neurofilament Proteins; Phenotype; Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sequestosome-1 Protein; Spinal Cord; tau Proteins; Ubiquitin; Valine | 2006 |
Alpha-synuclein in the nucleus accumbens induces changes in cocaine behaviour in rats.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Behavior, Animal; Cell Line, Transformed; Cocaine; Dopamine Uptake Inhibitors; Doxycycline; Histidine; Humans; Lentivirus; Locomotion; Nucleus Accumbens; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; Self Administration; Time Factors; Transfection | 2007 |
Products of Cu(II)-catalyzed oxidation of alpha-synuclein fragments containing M1-D2 and H50 residues in the presence of hydrogen peroxide.
Topics: alpha-Synuclein; Amino Acid Sequence; Binding Sites; Catalysis; Cations, Divalent; Chromatography, High Pressure Liquid; Copper; Histidine; Hydrogen Peroxide; Hydrogen-Ion Concentration; Lysine; Methionine; Molecular Sequence Data; Oxidation-Reduction; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulfones | 2008 |
Metal binding to alpha-synuclein peptides and its contribution to toxicity.
Topics: alpha-Synuclein; Amino Acid Sequence; Binding Sites; Cell Line, Tumor; Copper; Histidine; Humans; Iron; Molecular Sequence Data; Peptides; Protein Structure, Tertiary | 2009 |
Structural characterization of a high affinity mononuclear site in the copper(II)-α-synuclein complex.
Topics: alpha-Synuclein; Coordination Complexes; Copper; Electron Spin Resonance Spectroscopy; Histidine; Humans; Lewy Bodies; Metalloproteins; Protein Binding | 2010 |
The role of His-50 of α-synuclein in binding Cu(II): pH dependence, speciation, thermodynamics and structure.
Topics: alpha-Synuclein; Amino Acid Sequence; Binding Sites; Circular Dichroism; Copper; Electron Spin Resonance Spectroscopy; Histidine; Humans; Hydrogen-Ion Concentration; Models, Molecular; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Thermodynamics | 2011 |
Internal and global protein motion assessed with a fusion construct and in-cell NMR spectroscopy.
Topics: alpha-Synuclein; Histidine; Magnetic Resonance Spectroscopy; Oligopeptides; Protein Stability; Recombinant Fusion Proteins; Ubiquitin | 2011 |
First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.
Topics: Aged; alpha-Synuclein; Asparagine; Brain; DNA Mutational Analysis; DNA-Binding Proteins; Family Health; Female; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Magnetic Resonance Imaging; Male; Parkinson Disease; Protein Serine-Threonine Kinases; RNA-Binding Protein FUS; Ubiquitin | 2012 |
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Topics: alpha-Synuclein; Glutamine; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree | 2013 |
Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pH.
Topics: alpha-Synuclein; Amino Acid Substitution; Buffers; Electrochemistry; Histidine; Humans; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Unfolded Protein Response | 2014 |
Bioinorganic chemistry of synucleinopathies: deciphering the binding features of Met motifs and His-50 in AS-Cu(I) interactions.
Topics: alpha-Synuclein; Amino Acid Sequence; Binding Sites; Cations, Monovalent; Copper; Histidine; Humans; Kinetics; Molecular Sequence Data; Oxidation-Reduction; Protein Binding; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Recombinant Proteins; Solutions; Thermodynamics | 2014 |
LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
Topics: alpha-Synuclein; Animals; Biomarkers; Chromatography, Liquid; Drosophila melanogaster; Fatty Acids; Histidine; Humans; Kynurenine; Mass Spectrometry; Metabolomics; Nucleotides; Parkinson Disease; Phenotype; Phenylalanine; Steroids; Tryptophan; Tyrosine | 2015 |
Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
Topics: alpha-Synuclein; Cell Death; Cells, Cultured; Histidine; Humans; Mutation; Neurons; Parkinson Disease; Protein Aggregates; Protein Processing, Post-Translational | 2015 |
Remote His50 Acts as a Coordination Switch in the High-Affinity N-Terminal Centered Copper(II) Site of α-Synuclein.
Topics: alpha-Synuclein; Aspartic Acid; Binding Sites; Copper; Electron Spin Resonance Spectroscopy; Histidine; Humans; Hydrogen-Ion Concentration; Models, Molecular; Peptides; Protein Aggregates; Protein Binding; Protein Folding; Solid-Phase Synthesis Techniques | 2015 |
A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.
Topics: alpha-Synuclein; Brain; DNA Mutational Analysis; Exons; Glutamic Acid; Histidine; Humans; Male; Middle Aged; Mutation; Pick Disease of the Brain; tau Proteins; Ubiquitin | 2015 |
The Involvement of His50 during Protein Disulfide Isomerase Binding Is Essential for Inhibiting α-Syn Fibril Formation.
Topics: alpha-Synuclein; Amino Acid Substitution; Amyloid; Animals; Histidine; Humans; Mutation, Missense; Parkinson Disease; Protein Disulfide-Isomerases | 2016 |
Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
Topics: alpha-Synuclein; Amino Acid Substitution; Animals; Cells, Cultured; Copper; Environment; Genetic Predisposition to Disease; Histidine; Humans; Inclusion Bodies; Kinetics; Mutation; Neurons; Phosphorylation; Protein Aggregates; Protein Aggregation, Pathological; Protein Conformation, alpha-Helical; Rats | 2016 |
D409H GBA1 mutation accelerates the progression of pathology in A53T α-synuclein transgenic mouse model.
Topics: alpha-Synuclein; Animals; Aspartic Acid; Brain Stem; Disease Progression; Endoplasmic Reticulum Stress; Gaucher Disease; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glucosylceramidase; Histidine; Humans; Longevity; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Mutation; Tyrosine 3-Monooxygenase | 2018 |
Isolated nigral degeneration without pathological protein aggregation in autopsied brains with LRRK2 p.R1441H homozygous and heterozygous mutations.
Topics: Aged; alpha-Synuclein; Astrocytes; Autopsy; DNA-Binding Proteins; Female; Gene Expression Regulation; Histidine; Homozygote; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Parkinsonian Disorders; Proline; Protein Aggregation, Pathological; Substantia Nigra; tau Proteins | 2018 |
An efficient method for recombinant production of human alpha synuclein in
Topics: alpha-Synuclein; Benzothiazoles; Chromatography, Affinity; Chromatography, High Pressure Liquid; Cloning, Molecular; Endopeptidases; Escherichia coli; Histidine; Humans; Industrial Microbiology; Potyvirus; Recombinant Fusion Proteins; Spectrometry, Fluorescence; Thioredoxins | 2020 |
Comparing the copper binding features of alpha and beta synucleins.
Topics: alpha-Synuclein; Amino Acid Sequence; beta-Synuclein; Binding Sites; Copper; Histidine; Methionine; Protein Binding | 2022 |
Photo-oxygenation of histidine residue inhibits α-synuclein aggregation.
Topics: alpha-Synuclein; Histidine; Humans; Lewy Bodies; Parkinson Disease; Respiratory Physiological Phenomena | 2023 |